Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Cash from Restructuring (2016)

Historic Cash from Restructuring for Trinity Biotech (TRIB) over the last 1 years, with Q4 2016 value amounting to $3.7 million.

  • Trinity Biotech's Cash from Restructuring changed N/A to $3.7 million in Q4 2016 from the same period last year, while for Dec 2016 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2016, which is N/A changed from last year.
  • As of Q4 2016, Trinity Biotech's Cash from Restructuring stood at $3.7 million.
  • Trinity Biotech's Cash from Restructuring's 5-year high stood at $3.7 million during Q4 2016, with a 5-year trough of $3.7 million in Q4 2016.